Predilife (XPAR:ALPRE) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALPRE Predilife SA XPAR:ALPRE
33 GF Score
Price €1.11
GF Value €18.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Predilife Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XPAR:ALPRE vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, Predilife's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Predilife Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Predilife's Short Interest distribution charts can be found below:

* The bar in red indicates where Predilife's Short Interest falls into.


XPAR:ALPRE
33GF Score
Predilife SA XPAR:ALPRE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Predilife (XPAR:ALPRE) Overvalued in 2026?

Based on GuruFocus' analysis, Predilife stock appears to be undervalued. The current stock price of €1.11 is trading 94% below its estimated GF Value™ of €18.40. GuruFocus considers Predilife to be Possible Value Trap.

Key valuation signals for XPAR:ALPRE:

  • Short Interest:
  • GF Value™: €18.40 vs. price of €1.11 (94% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALPRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Predilife Business Description

Other Exchanges 0GA:Germany
Address 39 rue Camille Desmoulins, Villejuif, Villejuif, FRA, 94805
Predilife SA develops solutions for predictive medicine, combining medical techniques (genetic tests, medical imaging) and mathematical models with a large amount of statistical data, which allows each individual to define their risk profile for the occurrence of various serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
33GF Score

Get the complete analysis for XPAR:ALPRE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.11
Price
€18.40
GF Value